StockNews.com started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Rating) in a research report report published on Thursday morning. The brokerage issued a buy rating on the stock. A number of other analysts also recently commented on the stock. HC Wainwright reiterated a buy rating and issued a $8.00 target price on […]